FDA Label for Tranexamic Acid
View Indications, Usage & Precautions
Tranexamic Acid Product Label
The following document was submitted to the FDA by the labeler of this product Emcure Pharmaceuticals Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Indications And Usage
Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
Package Label.Principal Display Panel
NDC 14593-318-01
Tranexamic Acid Injection, USP
1000 mg/10 mL
(100 mg/mL)
Intravenous Use Only
Rx only
10 mL Single-Dose Vial
* Please review the disclaimer below.
